The likelihood of being obese was higher in participants with CKD stage 3a (adjusted OR 1.30, 95% CI = 1.09 to 1.55) or stage 3b (adjusted OR 1.91, 95% CI = 1.24 to 2.94), comorbidities (i.e., ischemic heart disease and HTN), or increased SBP, DBP, total cholesterol, Hb level, or FBG. Here, GSTM1 is linked to chronic kidney disease.